FDA has granted full approval to Takeda Pharmaceuticals U.S.A., Inc. for a new drug application, a milestone that will significantly bolster the company’s commercial portfolio and reinforces Takeda’s competitive position in the U.S. market.
FDA has granted full approval to Takeda Pharmaceuticals U.S.A., Inc. for a new drug application, a milestone that will significantly bolster the company’s commercial portfolio and reinforces Takeda’s competitive position in the U.S. market.